Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence

Context: Epidermal growth factor receptor (EGFR) is overly expressed in esophageal squamous cell carcinoma (ESCC) and is important prognostic and predictive biomarker. Nimotuzumab is a humanized anti-EGFR monoclonal antibody and has documented promising clinical outcomes and survival rates in variou...

Full description

Bibliographic Details
Main Authors: Sundaram Subramanian, Nithya Sridharan, V Balasundaram, Sameer Chaudhari
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=112;epage=115;aulast=Subramanian

Similar Items